Faith Nathan, MD, Oncology, Moorestown, NJ

FaithENathanMD

Oncology Moorestown, NJ

Genitourinary Oncology, Hematologic Oncology, Thoracic Cancer

Director, Global Clinical Research Oncology, Bristol-Myers Squibb

Dr. Nathan is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Nathan's full profile

Already have an account?

Education & Training

  • Medical College of Pennsylvania and Hospital
    Medical College of Pennsylvania and HospitalFELLOWSHIP
  • Cooper University Hospital
    Cooper University HospitalRESIDENCY
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolMEDICAL_SCHOOL

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1988 - 2006
  • NJ State Medical License
    NJ State Medical License 1987 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Pain in castration-resistant prostate cancer with bone metastases: a qualitative study  
    Gater A, Abetz-Webb L, Battersby C, Parasuraman B, McIntosh S, Nathan F, Piault EC, Health & Quality of Life Outcomes, 2011
  • Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population  
    Engel-Nitz NM, Alemayehu B, Parry D, Nathan F, Cancer management and research, 2011
  • A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advan...  
    Chouaid C, Nathan F, Pemberton K, Morris T, Cancer Chemother Pharmacol, 2011
  • Join now to see all

Professional Memberships